A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides
Kailu Yang, Chuchu Wang, Francesco Topi…·Axel T. Brünger
This study designs and validates protease-resistant antiviral peptides that inhibit SARS-CoV-2 fusion, showing improved efficacy in vitro and in vivo.